Professional Documents
Culture Documents
Ajaz Rajita Maam 2.0
Ajaz Rajita Maam 2.0
INTRODUCTION
Cipla Limited, together with its subsidiaries, manufactures, develops, and sells
pharmaceutical products in India, the United States, South Africa, and
internationally. The company operates through Pharmaceuticals and New ventures
segments. It also offers active pharmaceutical ingredients; and formulations in
various therapeutic areas, such as MI, angina, heart failure, hypertension,
arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology,
oncology, cardio-metabolism, child health, infectious diseases and critical care,
hepatitis, women's health, ophthalmology, and neuro psychiatry. In addition, the
company provides respiratory products, including inhalers and nasal sprays, as
well as other respiratory products consists of injectables and biosimilars. Further,
it offers Easy lax and Easy lax L, a liquid paraffin for constipation. Cipla Limited
was incorporated in 1935 and is based in Mumbai, India.
CIPLA LIMITED BALANCE SHEET
CIPLA LIMITED INCOME STATEMENT
CIPLA LIMITED COMPARATIVE BALANCE SHEET
Comparative balance sheet for the years 2020, 2021, 2022, and 2023
Category 2020 Value 2021 Value 2022 Value 2023 Value Absolute Change (2020-2023) Percentage Change (2020-2023)
Total Assets 236,625,600 251,518,900 271,011,200 294,632,800 58,007,200 24.5%
Total Liabilities 76,052,800 65,663,000 59,837,400 57,497,400 -18,555,400 -24.4%
Total Equity 160,572,800 185,855,900 211,173,800 237,135,400 76,562,600 47.7%
Common Stock Equity 157,630,000 183,265,300 208,416,900 234,077,800 76,447,800 48.5%
Capital Lease Obligations 2,727,700 2,588,500 2,316,400 2,827,600 99,900 3.7%
Net Tangible Assets 109,289,300 134,909,800 160,009,000 188,937,800 79,648,500 72.9%
Working Capital 73,130,400 86,179,600 98,143,300 121,652,800 48,522,400 66.4%
Invested Capital 185,794,300 200,820,900 216,658,300 239,399,200 53,604,900 28.8%
Tangible Book Value 109,289,300 134,909,800 160,009,000 188,937,800 79,648,500 72.9%
Total Debt 30,892,000 20,144,100 10,557,800 8,149,000 -22,743,000 -73.6%
Net Debt 20,740,500 1,464,000 - - -19,276,500 -93.0%
Share Issued 806,235 806,463 807,151 807,151 1,916 0.2%
Ordinary Shares Number 806,235 806,463 807,151 807,151 1,916 0.2%
Common size balance sheet of Cipla Limited as on mar 2021,2022 and 2023
(in cr).
Deferred Tax Assets (Net) 1,429.00 955 970 779 -33.17% 1.57% -19.66%
Current Investments 4,006.00 2,037.00 5,467.00 4,476.00 -49.15% 168.14% -18.08%
Current Liabilities
Trade Receivables 15,459.00 16,394.00 18,966.00 20,773.00 6.05% 15.66% 9.54%
Cash And Cash
Equivalents 13,562.00 17,612.00 12,270.00 6,534.00 29.86% -30.35% -46.71%
Other Current Assets 10,486.00 12,010.00 15,515.00 20,008.00 14.53% 29.19% 29.03%
Total Capital and
Liabilities
Financial Ratios for The Year 2019,2020,2021,2022,2023